PATENT CLAIM ANALYSIS

Application Number: 16155612
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-06
Patent Classification: ["514", "629000"]

Abstract:
The use of oral colchicine solutions in combination with other therapeutics, while minimizing toxic drug to drug interactions are described herein. Related compositions are also provided.

Claim (Index 25):
The method of  claim 1 , wherein the colchicine sensitive disorder is selected from gout, prophylactic treatment of gout, familial Mediterranean fever (FMF), prophylactic treatment of FMF, pericarditis, prophylactic treatment of pericarditis, Beh\u00e7et's disease, atrial fibrillation, prophylactic treatment of atrial fibrillation, amyloidosis, calcium pyrophosphate deposition disease (pseudogout), cirrhosis of the liver, sarcoid arthritis, inflammatory diseases, and disk diseases and related spinal disorders.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 97.0
- Lexical Diversity: 1.11538
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16155571', '15848498', '13973897', '14567005', '13092459']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7846861449263061
- 35 USC 102 Novelty (BERT): 0.6413765858695227
- Combined Prediction Score: 0.7703551890206278
- Mean Citation Score: 443.995968
- Max Citation Score: 693.34393
- Similarity Product: 529.4019197819465

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test